The Food and Drug Administration today proposed reclassifying surgical staplers for internal use as moderate-risk rather than low-risk medical devices. The change would allow the agency to require premarket review of the devices and establish special controls such as mandatory performance testing of the device’s features, usability and labeling. In addition, FDA announced draft guidance to help manufacturers ensure their labeling provides adequate information for use, and a May 30 advisory committee meeting to receive expert input on the proposed reclassification and guidance. The agency has received reports of more than 9,000 serious injuries and 366 patient deaths associated with the devices since 2011, and last month issued additional safety recommendations for health care providers using the devices.

Related News Articles

Headline
The Food and Drug Administration yesterday revised its emergency use authorizations for all COVID-19 antigen tests to authorize serial testing and require…
Headline
Exela Pharma Sciences this week recalled 49 lots of sodium bicarbonate injection because the vial may break while preparing the product for administration…
Headline
Philips Respironics has recalled more than 17 million masks used with Bilevel Positive Airway Pressure and Continuous Positive Airway Pressure machines because…
Headline
The Food and Drug Administration today announced a Class 1 recall of devices used to access blood vessels through a patient’s bone because the devices may…
Headline
The Environmental Protection Agency today released a list of commercial medical device sterilizing facilities where lifetime risk from ethylene oxide emissions…
Headline
Baxter Healthcare Corp. recently recalled its Abacus software for ordering compounded liquid medications due to a risk the printed bag labels may contain…